Cargando…
Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders
BACKGROUND: To assess comorbid DSM-IV-TR Axis I disorders in adolescent inpatients referred for treatment of substance use disorders. METHODS: 151 patients (mean age 16.95 years, SD = 1.76; range 13 - 22) were consecutively assessed with the Composite International Diagnostic Interview (CIDI) and st...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956714/ https://www.ncbi.nlm.nih.gov/pubmed/20920182 http://dx.doi.org/10.1186/1753-2000-4-25 |
_version_ | 1782188181023621120 |
---|---|
author | Langenbach, Tobias Spönlein, Alexandra Overfeld, Eva Wiltfang, Gaby Quecke, Niklas Scherbaum, Norbert Melchers, Peter Hebebrand, Johannes |
author_facet | Langenbach, Tobias Spönlein, Alexandra Overfeld, Eva Wiltfang, Gaby Quecke, Niklas Scherbaum, Norbert Melchers, Peter Hebebrand, Johannes |
author_sort | Langenbach, Tobias |
collection | PubMed |
description | BACKGROUND: To assess comorbid DSM-IV-TR Axis I disorders in adolescent inpatients referred for treatment of substance use disorders. METHODS: 151 patients (mean age 16.95 years, SD = 1.76; range 13 - 22) were consecutively assessed with the Composite International Diagnostic Interview (CIDI) and standardized clinical questionnaires to assess mental disorders, symptom distress, psychosocial variables and detailed aspects of drug use. A consecutively referred subgroup of these 151 patients consisting of 65 underage patients (mean age 16.12, SD = 1.10; range 13 - 17) was additionally assessed with the modules for attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) using The Schedule for Affective Disorders and Schizophrenia for school-aged children (K-SADS-PL). RESULTS: 128 (84.8%) of the 151 patients were dependent on at least one substance, the remaining patients fulfilled diagnostic criteria for abuse only. 40.5% of the participants fulfilled criteria for at least one comorbid present Axis I disorder other than substance use disorders (67.7% in the subgroup additionally interviewed with the K-SADS-PL). High prevalences of present mood disorder (19.2%), somatoform disorders (9.3%), and anxiety disorders (22.5%) were found. The 37 female participants showed a significantly higher risk for lifetime comorbid disorders; the gender difference was significantly pronounced for anxiety and somatoform disorders. Data from the underage subgroup revealed a high prevalence for present CD (41.5%). 33% of the 106 patients (total group) who were within the mandatory school age had not attended school for at least a two-month period prior to admission. In addition, 51.4% had been temporarily expelled from school at least once. CONCLUSIONS: The present data validates previous findings of high psychiatric comorbidity in adolescent patients with substance use disorders. The high rates of school refusal and conduct disorder indicate the severity of psychosocial impairment. |
format | Text |
id | pubmed-2956714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29567142010-10-19 Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders Langenbach, Tobias Spönlein, Alexandra Overfeld, Eva Wiltfang, Gaby Quecke, Niklas Scherbaum, Norbert Melchers, Peter Hebebrand, Johannes Child Adolesc Psychiatry Ment Health Research BACKGROUND: To assess comorbid DSM-IV-TR Axis I disorders in adolescent inpatients referred for treatment of substance use disorders. METHODS: 151 patients (mean age 16.95 years, SD = 1.76; range 13 - 22) were consecutively assessed with the Composite International Diagnostic Interview (CIDI) and standardized clinical questionnaires to assess mental disorders, symptom distress, psychosocial variables and detailed aspects of drug use. A consecutively referred subgroup of these 151 patients consisting of 65 underage patients (mean age 16.12, SD = 1.10; range 13 - 17) was additionally assessed with the modules for attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) using The Schedule for Affective Disorders and Schizophrenia for school-aged children (K-SADS-PL). RESULTS: 128 (84.8%) of the 151 patients were dependent on at least one substance, the remaining patients fulfilled diagnostic criteria for abuse only. 40.5% of the participants fulfilled criteria for at least one comorbid present Axis I disorder other than substance use disorders (67.7% in the subgroup additionally interviewed with the K-SADS-PL). High prevalences of present mood disorder (19.2%), somatoform disorders (9.3%), and anxiety disorders (22.5%) were found. The 37 female participants showed a significantly higher risk for lifetime comorbid disorders; the gender difference was significantly pronounced for anxiety and somatoform disorders. Data from the underage subgroup revealed a high prevalence for present CD (41.5%). 33% of the 106 patients (total group) who were within the mandatory school age had not attended school for at least a two-month period prior to admission. In addition, 51.4% had been temporarily expelled from school at least once. CONCLUSIONS: The present data validates previous findings of high psychiatric comorbidity in adolescent patients with substance use disorders. The high rates of school refusal and conduct disorder indicate the severity of psychosocial impairment. BioMed Central 2010-09-28 /pmc/articles/PMC2956714/ /pubmed/20920182 http://dx.doi.org/10.1186/1753-2000-4-25 Text en Copyright ©2010 Langenbach et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Langenbach, Tobias Spönlein, Alexandra Overfeld, Eva Wiltfang, Gaby Quecke, Niklas Scherbaum, Norbert Melchers, Peter Hebebrand, Johannes Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders |
title | Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders |
title_full | Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders |
title_fullStr | Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders |
title_full_unstemmed | Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders |
title_short | Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders |
title_sort | axis i comorbidity in adolescent inpatients referred for treatment of substance use disorders |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956714/ https://www.ncbi.nlm.nih.gov/pubmed/20920182 http://dx.doi.org/10.1186/1753-2000-4-25 |
work_keys_str_mv | AT langenbachtobias axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders AT sponleinalexandra axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders AT overfeldeva axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders AT wiltfanggaby axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders AT queckeniklas axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders AT scherbaumnorbert axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders AT melcherspeter axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders AT hebebrandjohannes axisicomorbidityinadolescentinpatientsreferredfortreatmentofsubstanceusedisorders |